
BIVI
Healthcare · Biotechnology · $12.1M market cap
$1.13-0.06 (-5.0%)Nov 13, 4:22 PM EST
Latest report
Time not confirmed
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Dec 31, 2025
EPS trend, 90 days to now · +81.6% over 90 days · 30-day revisions 0 up, 1 down
Beat estimates in 0 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Nov 6, 2026 | Time not confirmed | — | -0.68 | — |
| Aug 12, 2026 | Time not confirmed | -0.52 | -0.70 | -34.6% |
| Jun 3, 2026 | Time not confirmed | — | -0.70 | — |
| Feb 25, 2026 | Time not confirmed | — | -0.77 | — |
| Nov 10, 2025 | After the close | -0.79 | -0.98 | -24.1% |
| Aug 15, 2025 | After the close | -3.60 | -11.05 | -206.9% |
| May 12, 2025 | After the close | -3.20 | -1.50 | +53.1% |
| Feb 11, 2025 | After the close | -16.00 | -4.60 | +71.3% |
| Nov 6, 2024 | After the close | -0.27 | -0.70 | -159.1% |
| Sep 30, 2024 | After the close | -0.15 | -0.80 | -432.1% |
| May 14, 2024 | After the close | -25.00 | -20.00 | +20.0% |
| Feb 13, 2024 | Before the open | -27.50 | -22.00 | +20.0% |
| Nov 8, 2023 | After the close | -31.00 | -29.00 |
BioVie Inc., a clinical-stage biopharmaceutical company, develops drug therapies to treat neurological and neurodegenerative disorders, and advanced liver disease in the United States. The company develops BIV201, that is in phase 3 for the treatment of life-threatening complications of liver cirrhosis and ascites due to hepatitis, nonalcoholic steatohepatitis, and alcoholism. It also develops Bezisterim, an…
| +6.5% |
| Aug 16, 2023 | After the close | -40.00 | -23.00 | +42.5% |
| May 12, 2023 | After the close | -35.50 | -43.00 | -21.1% |
| Feb 10, 2023 | After the close | -25.25 | -50.00 | -98.0% |
| Nov 4, 2022 | After the close | -28.50 | -38.00 | -33.3% |
| Sep 27, 2022 | After the close | -0.37 | -0.33 | +10.8% |
| May 11, 2022 | After the close | -71.00 | -28.00 | +60.6% |
| Feb 8, 2022 | Before the open | -41.00 | -22.00 | +46.3% |
| Nov 10, 2021 | After the close | -0.23 | -0.23 | 0.0% |
| Aug 30, 2021 | After the close | -232.00 | -1018.77 | -339.1% |
| May 10, 2021 | After the close | -23.00 | -22.00 | +4.3% |
| Jan 29, 2021 | After the close | -12.00 | -22.00 | -83.3% |
| Nov 5, 2020 | After the close | — | -3.28 | — |
| Aug 6, 2020 | After the close | — | -3.68 | — |
| May 13, 2020 | Time not confirmed | — | -0.07 | — |
| Feb 13, 2020 | Time not confirmed | — | 1.29 | — |
| Nov 19, 2019 | Time not confirmed | — | -5.06 | — |
| Sep 27, 2019 | Time not confirmed | — | -0.25 | — |
| Jun 30, 2019 | Time not confirmed | — | -0.25 | — |
| Mar 31, 2019 | Time not confirmed | — | -0.34 | — |
| Dec 31, 2018 | Time not confirmed | — | -0.20 | — |
| Sep 30, 2018 | Time not confirmed | — | -0.20 | — |
| Jun 30, 2018 | Time not confirmed | — | -0.73 | — |
| Mar 31, 2018 | Time not confirmed | — | -0.89 | — |